If more Medicare beneficiaries with obesity or overweight gain access to GLP-1s based on other approved uses for these medications, that could reduce the cost of proposed legislation to lift the statutory prohibition on Medicare coverage of anti-obesity drugs
[84] While central obesity can be obvious just by looking at the naked body (see the picture), the severity of central obesity is determined by taking waist and hip measurements
Individual results vary, but the data is compelling
Vivek Lal, a double-board certified and university-affiliated physician based in Birmingham, Alabama
While both are effective, tirzepatide appears to offer more robust outcomes in terms of weight loss and glycaemic control, likely due to its dual mechanism
Which Option Is Right for Your Weight Loss Goals